Clinical Trial Update: An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial update evaluating imaging approaches for post-operative staging in kidney cancer, comparing 89Zr-DFO-GmAb PET/CT to contrast-enhanced CT for det…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Renal Cell Carcinoma
• Sarcomatoid Renal Cell Carcinoma

Drugs mentioned

• 89Zr-DFO-GmAb PET/CT

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Clear Cell Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma | Phase 2 | Status: RECRUITING